What question did this study set out to answer?

The research aims to explore the signaling pathways affected by diabetes-induced jejunal mucosal hyperplasia, focusing on MAP-K and p34 cdc2 kinase activities.

February 12, 2026Journal of Investigative Medicine

Effects of Diabetes and Difluoromethylornithine Treatment on Hyperplasia, Activity of MAP-Kinase, and Activity and Association with Cyclin B of p34 cdc2 Kinase in Rat Jejunal Mucosa

View Full Paper

Ask AI

Bookmark

The research aims to explore the signaling pathways affected by diabetes-induced jejunal mucosal hyperplasia, focusing on MAP-K and p34 cdc2 kinase activities.
Analyzed untreated and DFMO-treated control rats alongside rats with streptozotocin-induced type I diabetes.
Conducted assays 10 days post-diabetes induction to measure jejunal mucosal weight and DNA content.
Examined activities of MAP-K and p34 cdc2 kinase, alongside their association with cyclin B.
Diabetic rats exhibited significant jejunal hyperplasia indicated by increased mucosal weight and DNA content.
Increased activities of MAP-K and p34 cdc2 kinase were observed in diabetic rats compared to controls.
DFMO administration prevented hyperplasia and reduced enzymatic activities in both diabetic and control groups.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Investigates diabetes-induced hyperplasia in the jejunal mucosa, highlighting potential signaling pathways and treatments.

Cite This Study

Parekh et al. (1998) studied this question.

synapsesocial.com/papers/698d6d445be6419ac0d52206 https://doi.org/10.1177/108155899804600213

View Full Paper

Ask AI

Bookmark

Effects of Diabetes and Difluoromethylornithine Treatment on Hyperplasia, Activity of MAP-Kinase, and Activity and Association with Cyclin B of p34 cdc2 Kinase in Rat Jejunal Mucosa

Key Points

Discussion

Implication

Cite This Study

Effects of Diabetes and Difluoromethylornithine Treatment on Hyperplasia, Activity of MAP-Kinase, and Activity and Association with Cyclin B of p34 cdc2 Kinase in Rat Jejunal Mucosa

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider